NVG-291 in Spinal Cord Injury Subjects

Recruiting

Phase 1

Phase 2

NVG-291NVG-291 in Spinal Cord Injury Subjects

Sponsor:

NervGen Pharma

Code:

NCT05965700

Conditions

Spinal Cord Injuries

Chronic Spinal Cord Injury

Subacute Spinal Cord Injury

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

NVG-291

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by NervGen Pharma on 2025-06-04.